Business Context and Reporting Period
This Form 8-K filing by Rocket Pharmaceuticals, Inc. (RCKT) reports a corporate governance event. The report date is September 29, 2025, covering an event effective September 30, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the resignation of Pedro Granadillo from the Board of Directors. The filing explicitly states that the resignation did not involve any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on future performance, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Confirm the effective date of Pedro Granadillo's resignation (September 30, 2025).
- Verify if a replacement director has been nominated or appointed to fill the vacancy.
- Review the Company's most recent 10-Q or 10-K for current financial status, as this 8-K contains no financial data.